Sep 06, 2016 12:01 pm UTC| Business
TEL AVIV, Israel, Sept. 06, 2016 -- VBL THERAPEUTICS (NASDAQ:VBLT), today announced it will present at the 18th Annual Rodman Renshaw Global Investment Conference, sponsored by H.C. Wainwright Co., LLC. The conference...
Sep 06, 2016 12:01 pm UTC| Business
TEL AVIV, Israel, Sept. 06, 2016 -- VBL THERAPEUTICS (NASDAQ:VBLT), today announced it will present at the 18th Annual Rodman Renshaw Global Investment Conference, sponsored by H.C. Wainwright Co., LLC. The conference...
Bio-Path Holdings to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Sep 06, 2016 12:00 pm UTC| Business
HOUSTON, Sept. 06, 2016 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic...
Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13
Sep 06, 2016 12:00 pm UTC| Business
CEO Lionel Ségard to discuss clinical updates and latest company developments PARIS and NEW YORK, Sept. 06, 2016 -- QuantumGenomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of...
Aclaris Therapeutics to Present at the Morgan Stanley 2016 Healthcare Conference
Sep 06, 2016 12:00 pm UTC| Business
MALVERN, Pa., Sept. 06, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President Chief Executive Officer, will present at the...
Valeritas to Present at the Rodman & Renshaw Global Investment Conference
Sep 06, 2016 12:00 pm UTC| Business
BRIDGEWATER, N.J., Sept. 06, 2016 -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer is scheduled to present at the Rodman Renshaw 18th Annual Global...
Chimerix to Present at the Morgan Stanley Global Healthcare Conference
Sep 06, 2016 12:00 pm UTC| Business
DURHAM, N.C., Sept. 06, 2016 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H, Chief Executive...